Non-HDL-Cholesterin

Non-HDL cholesterol (Non-HDL-C) is a calculated biomarker that represents the total cholesterol content of all atherogenic lipoproteins, excluding high-density lipoprotein cholesterol (HDL-C). It is calculated by subtracting HDL-C from total cholesterol. Non-HDL-C provides a comprehensive measure of cholesterol that is potentially harmful to cardiovascular health. Clinically, non-HDL-C is significant as it encompasses all lipoproteins considered atherogenic, including low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and lipoprotein(a). Elevated non-HDL-C levels are associated with increased risk of cardiovascular diseases such as myocardial infarction and stroke. For athletes and biohackers, maintaining optimal non-HDL-C levels is crucial for cardiovascular health and longevity. Research has shown that variability in non-HDL-C levels can contribute to residual cardiovascular risk, independent of mean levels. It is important to monitor non-HDL-C as part of a comprehensive lipid profile, especially in individuals with metabolic syndrome or those undergoing lipid-lowering therapy. Caveats include the need for fasting before testing to ensure accurate results, as non-fasting samples can lead to overestimation of non-HDL-C due to postprandial lipemia. Additionally, factors such as recent intense exercise or acute illness can interfere with lipid levels, necessitating careful timing of the test.